A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
Big Ten Cancer Research Consortium
Big Ten Cancer Research Consortium
Inspirna, Inc.
Intensity Therapeutics, Inc.
Anaveon AG
University of Chicago
Bristol-Myers Squibb
Bristol-Myers Squibb
Duke University
Massachusetts General Hospital
Gary Onik MD
NYU Langone Health
Bristol-Myers Squibb